![2024 ASCO® Annual Meeting Insights Hub](http://media.vumedi.com/thumbs/channel_logo/2024/6/3eb80c08-a2a4-4a36-a405-93c404d5b3cc.png.200x0_q85.png)
2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"
By
ecancer
FEATURING
Robert Jotte
By
ecancer
FEATURING
Robert Jotte
194 views
June 21, 2024
Comments 0
Login to view comments.
Click here to Login
Lung